Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2010
07/14/2010EP2205265A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
07/14/2010EP2205259A1 Method of regulating the th17 pathway and its associated metabolic impact
07/14/2010EP2205069A1 Combretum laurifolium mart. extract and methods of extracting and using such extract
07/14/2010EP1539141B1 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010EP1261357B1 Isolation and transplantation of retinal stem cells
07/14/2010EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon
07/14/2010EP1203587B1 A medicament and method for the production thereof
07/14/2010CN101778830A Particulates of a crth2 antagonist
07/14/2010CN101775061A Ilex latifolia thunb saponin compound
07/14/2010CN101775058A Preparation and application of pharmaceutic preparation of 11-carbonyl-betal- acetyl mastic acid and derivatives thereof extracted from frankincense
07/14/2010CN101773650A Chinese medicinal composition for treating clonic convulsion and preparation method thereof
07/14/2010CN101773649A Chinese medicine composition for treating acute abdomen and preparation method thereof
07/14/2010CN101773644A Traditional Chinese medicine for moxa treatment of neurodynia after paraplegia
07/14/2010CN101773618A Drug for treatment of cold
07/14/2010CN101773614A Drug for treatment of rheumatic heart disease
07/14/2010CN101773613A Drug for treatment of rheumatic heart disease
07/14/2010CN101773608A Medicine for treating rheumatoid arthritis or resembling rheumatoid arthritis and usage
07/14/2010CN101773577A Kanto tea bath package for curing rheumatism, arthritis and senile degenerative joint diseases
07/14/2010CN101773567A Bone injury ache plaster
07/14/2010CN101773561A Chinese medicine composition with functions of tonifying kidney, invigorating blood circulation and relieving pain and preparation method thereof
07/14/2010CN101773551A External-use medicine composition of traditional Mongolian medicine for curing soft tissue injury
07/14/2010CN101773550A Medicinal wine for treating rheumatalgia and preparation method thereof
07/14/2010CN101773537A Slow-release microspheres prepared from active ingredients of tripterygium wilfordii and preparation method thereof
07/14/2010CN101773535A External application Chinese medicine composition for treating hemorrhoids and preparation method thereof
07/14/2010CN101773523A Traditional Chinese medicine antimanic drug for treatment of hyperlipemia and preparation thereof
07/14/2010CN101773511A Compound topical combination drug for treatment of acne and preparation method thereof
07/14/2010CN101773503A Leukotriene antagonist and antihistaminics composition
07/14/2010CN101773493A New application of medicine compound brazilein
07/14/2010CN101773492A Medicine for treating acute bronchitis and preparation method thereof
07/14/2010CN101773487A Exotic plant Flaveria bidentis active ingredient chlorogenic acid intercalation hydrotalcite and preparation method thereof
07/14/2010CN101773475A Preparation method of capsicine micro spheres
07/14/2010CN101773472A Nimesulide dry suspension and preparation method thereof
07/14/2010CN101773465A Polymer micelle medicine carrying system using amino acid as stabilizing agent
07/14/2010CN101574325B Sodium dichlorophenolate sustained-release tablet and method for controlling sustained-release of sodium dichlorophenolate sustained-release tablet
07/14/2010CN101214318B Medicinal liquor for treating rheumatism, rheumatoid and various hyperosteogeny
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754769 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis
07/13/2010US7754753 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754422 Method of judging inflammatory disease
07/13/2010US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010CA2557536C Amino alcohol compound
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2457451C Naphthyridine derivatives
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2414239C Analgesic anti-inflammatory patch for topical application
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases
07/13/2010CA2349503C Particles coated with granulated crystalline ibuprofen
07/13/2010CA2347713C Contulakin-g, analogs thereof and uses therefor
07/13/2010CA2345932C Peptide-based carrier devices for stellate cells
07/08/2010WO2010078466A2 Sand fly salivary proteins with anti-complement activity and methods of their use
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010077680A2 Compositions of protein receptor tyrosine kinase inhibitors
07/08/2010WO2010077586A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
07/08/2010WO2010076879A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010WO2010076566A2 Indoles useful in the treatment of inflammation
07/08/2010WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
07/08/2010WO2010075861A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
07/08/2010WO2010053902A3 Tryptase enzyme inhibiting aminothiophenols
07/08/2010WO2010051541A3 Compositions containing delta-9-thc-amino acid esters and process of preparation
07/08/2010WO2010049144A3 Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity
07/08/2010WO2010048559A3 Phenylpyrazole inhibitors of store operated calcium release
07/08/2010WO2010048365A3 Therapeutic peptide bioconjugates
07/08/2010WO2010034011A3 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
07/08/2010WO2010027189A3 A new use for homoisoflavanone or a salt thereof
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173952 Metalloprotein inhibitors
07/08/2010US20100173947 New Indications for Direct Thrombin Inhibitors
07/08/2010US20100173941 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
07/08/2010US20100173937 Use of tetrakis-quaternary ammonium salts as pain modulating agents
07/08/2010US20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia
07/08/2010US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
07/08/2010US20100173911 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES
07/08/2010US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using
07/08/2010US20100173901 Substituted Heterocyclic Compounds
07/08/2010US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
07/08/2010US20100173889 Substituted Pyrimidine and Triazine Compounds
07/08/2010US20100173885 Organometeallic compounds
07/08/2010US20100173881 Compositions for the treatment of inflammatory disorders
07/08/2010US20100173876 Oil-based nsaid compositions and methods for making and using same
07/08/2010US20100173858 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals
07/08/2010US20100173856 Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances
07/08/2010US20100173848 Methods of inhibiting chemokine binding to chemokines receptors
07/08/2010US20100173845 Use of fertirelin and delta-endorphin as therapeutic agents
07/08/2010US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen
07/08/2010US20100173838 Novel process for the preparation of cyclosporin derivatives
07/08/2010US20100173834 Cyclic peptide melanocortin receptor ligands
07/08/2010US20100173823 Alpha2c adrenoreceptor agonists
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1272